Sanofi
SNY
503 hedge funds and large institutions have $9.71B invested in Sanofi in 2017 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 126 increasing their positions, 196 reducing their positions, and 51 closing their positions.
107% more call options, than puts
Call options by funds: $22.2M | Put options by funds: $10.7M
45% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 51
4% more funds holding
Funds holding: 484 → 503 (+19)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.29% less ownership
Funds ownership: 18.15% → 17.86% (-0.29%)
15% less capital invested
Capital invested by funds: $11.5B → $9.71B (-$1.77B)
36% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 196
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$53.1M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$19.3M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.4M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$9.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$82.1M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$73.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$42.8M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$30M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$25.5M |
SNY Hedge Fund Activity: Q4 2017 in Review
503 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2017, worth a combined $9.71B — down 15% from $11.5B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new SNY positions and 51 closed out — a net gain of 23 holders — while 126 added to existing stakes and 196 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $90.6M. The largest seller was Bank of America, cutting an estimated $82.1M.
- 503 institutional investors held Sanofi (SNY) as of Q4 2017, up from 484 in Q3 2017.
- Funds reported $9.71B of Sanofi stock for Q4 2017, down 15% quarter-over-quarter.
- 74 funds opened new Sanofi positions in Q4 2017 and 51 closed out, a net change of +23 holders.
- The largest Sanofi buyer in Q4 2017 was Fidelity Investments, an estimated $90.6M added.
- The largest Sanofi seller in Q4 2017 was Bank of America, an estimated $82.1M sold.
Based on aggregated 13F filings for Q4 2017.